Dementia patients and their families have been yearning for new, and hopefully more effective treatment options. This is true both for cognition as well as for the neuropsychiatric symptoms that invariably accompany the illness and prove so challenging for all involved.
Since the dementia clinical trial landscape has seen so many failures over the past 15 years, it is more important than ever that sponsors work with an experienced partner that can deliver the highest data quality.
We have significant experience beyond Alzheimer’s that includes Frontotemporal Lobar Degeneration (FTLD), Dementia with Lewy Bodies (DLB), and Parkinson’s Disease Dementia (PDD), among others. Additionally, our scientific expertise extends beyond cognition to also include neuropsychiatric symptoms associated with dementia.
Our solution, Rater Station, offers enhanced eClinRO functions and features for clinician administered scales including interviews, edit checks and alerts, automated scoring as applicable, and on-screen guidance. It works alongside our patient engagement solution, sponsor and site portals, and interactive response technology (IRT).
Our Data Quality Analytics are a proprietary risk-based monitoring solution that extracts insights from clinical data. It has been used for dementia studies to identify quality issues at the study, site, rater, and subject level in near real-time, and our analytics experience is unmatched in the industry.
Download our brochure to learn more about how our solutions enhance dementia research studies.